The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The gene symbol lincRNA.S6902 is ambiguous and the literature is extremely limited for this specific protein. For the identity specified by the user—UniProt Q9VFA8, FlyBase gene FBgn0259823/CG42404, organism Drosophila melanogaster—the defensible annotation is a poorly characterized, computationally predicted IDD/VWFC-domain-containing gene product. No retrieved study establishes its primary molecular function, catalytic activity, substrate, binding partner, pathway, or subcellular/extracellular location.
The name lincRNA.S6902 is especially problematic because it resembles a long-intergenic-noncoding-RNA designation, whereas the supplied UniProt record describes a protein containing a von Willebrand factor type-C-like domain. This likely reflects historical gene-model or nomenclature changes, but the available literature does not resolve them. Accordingly, this report does not transfer findings from similarly named genes or unrelated VWFC-domain proteins.
| Topic | Conclusion | Evidence type | Confidence |
|---|---|---|---|
| Identity | Target is UniProt Q9VFA8, associated with CG42404 / lincRNA.S6902, in Drosophila melanogaster (DROME). | User-supplied UniProt annotation; exact-identifier verification | High for the specified research target |
| Nomenclature | The lincRNA-like name lincRNA.S6902 is incongruent with the supplied protein-coding annotation (“VWFC domain-containing protein”); the record may reflect historical gene-model changes, so RNA-versus-protein status should not be inferred from the symbol alone. | Comparison of user-supplied names and protein annotation | Moderate; unresolved without current record-level curation evidence |
| Historical aliases | Supplied aliases include CG31154, CG34128, CG4285, and CG42404. The literature excerpts do not independently establish every alias mapping. | User-supplied UniProt annotation plus literature identifier checks | Moderate |
| Predicted domains | Supplied InterPro annotations are IDD (IPR042378) and VWF_dom/VWFC (IPR001007). These support classification as a domain-containing protein but do not by themselves establish ligand, reaction, pathway, or cellular location. | User-supplied computational database annotation | Moderate for domain presence; low for functional interpretation |
| Direct literature | The only exact-target literature retrieved consists of inclusion in Drosophila wing gain-of-function/RNAi screening tables published in 2009 and 2012; neither provides a gene-specific biochemical mechanism (cruz2009againoffunctionscreen pages 13-14, cruz2009againoffunctionscreen pages 8-9, molnar2012geneticannotationof pages 4-5). | Peer-reviewed high-throughput genetic screens | High that it was listed; low for mechanistic annotation |
| 2012 screen result | The visible CG42404 table column contains “nE” for the in-situ annotation and “wt” for the RNAi result, with numeric entries 0 and 2 in preceding rows; the excerpt supplies no safely interpretable gene-specific sample size, effect estimate, or statistical test (molnar2012geneticannotationof pages 4-5). | Peer-reviewed screen table | Moderate for the codes; low for biological interpretation |
| Molecular function | Unknown. No catalytic activity, substrate, receptor/ligand interaction, structural role, or binding specificity has been experimentally demonstrated for this exact gene product in the retrieved evidence. | Evidence-gap assessment | High |
| Localization | Unknown. A VWFC-domain prediction alone does not justify claiming secretion, extracellular-matrix residence, or any specific cellular compartment. | Evidence-gap assessment constrained by domain-only annotation | High |
| Pathway | Unknown. No exact-gene evidence connects CG42404 to BMP, Notch, extracellular-matrix, or another signaling/biochemical pathway; functions of unrelated VWFC proteins cannot be transferred automatically. | Evidence-gap assessment | High |
| Developmental role | Wing-screen inclusion supplies only weak candidate-level evidence; the available tables do not establish that CG42404 is required for wing growth or patterning, and the reported wt RNAi code argues against a detectable phenotype under that specific assay condition (cruz2009againoffunctionscreen pages 8-9, molnar2012geneticannotationof pages 4-5). | High-throughput genetic evidence | Low-to-moderate |
| Recent research | No 2023–2024 publication dedicated to Q9VFA8, CG42404, or lincRNA.S6902 was retrieved. This is a search result, not proof that no such publication exists. | Exact-identifier literature-search outcome | Moderate |
| Applications | No validated research, clinical, agricultural, diagnostic, or biotechnological application specific to this gene product was identified. | Evidence-gap assessment | High |
| Overall annotation | The defensible description is poorly characterized predicted IDD/VWFC-domain-containing product. Secretion, BMP regulation, enzymatic activity, substrate specificity, and pathway membership remain hypotheses requiring direct testing. | Integrated assessment of supplied annotation and peer-reviewed evidence | High |
Table: Evidence-tier summary for the identity and functional annotation of Drosophila Q9VFA8/CG42404. It separates supplied database predictions from limited screen evidence and explicitly marks unsupported mechanistic claims.
The research target was restricted to the supplied identity:
lincRNA.S6902, BcDNA:SD12744, CG31154, CG34128, CG4285, Dmel\CG42404, and Dmel_CG42404Exact searches for Q9VFA8 and lincRNA.S6902 produced no dedicated papers. CG42404 was found in two D. melanogaster wing-screen publications. The older paper also contains CG4285, but the paper excerpt does not itself prove that CG4285 and CG42404 are historical versions of the same model; that equivalence comes from the supplied UniProt annotation. CG4285 appears in a screen-table row at cytological position 88E4, but the compressed table does not provide a safely interpretable gene-specific molecular conclusion (cruz2009againoffunctionscreen pages 13-14).
Thus, the organism and target accession are clear, but the gene symbol is nomenclaturally ambiguous. No literature concerning another organism or similarly named protein was used.
The supplied record calls Q9VFA8 a “VWFC domain-containing protein” and assigns VWF_dom/VWFC (IPR001007) plus IDD (IPR042378). A domain match identifies a sequence region with similarity to a known structural module; it does not demonstrate the full protein’s biochemical activity.
VWFC domains occur in diverse extracellular and secreted proteins, including proteins that bind growth factors or contribute to extracellular structures. Nevertheless, domain presence alone cannot establish that Q9VFA8 is secreted, binds BMP-family ligands, participates in extracellular matrix, or has any particular ligand specificity. Those conclusions require corroborating sequence features—such as an experimentally validated signal peptide—and direct localization or interaction data. No such exact-gene evidence was retrieved.
Likewise, neither supplied domain constitutes evidence of an enzyme active site. Q9VFA8 should therefore not be annotated as an enzyme, and no reaction, substrate, cofactor, or catalytic specificity can presently be assigned.
Unknown. No exact-gene study demonstrates:
The safest functional phrase is: “predicted IDD/VWFC-domain-containing protein of unknown molecular function.”
No pathway membership is established. In particular, there is no direct evidence linking CG42404 to BMP/Dpp, Notch, extracellular-matrix assembly, immunity, or another signaling or biochemical pathway. Although other VWFC-containing proteins can participate in such processes, transferring their functions to Q9VFA8 solely from one shared domain would be unjustified.
The 2009 paper lists CG42404 within a gain-of-function screening dataset for growth and pattern formation of the fly wing, but its compressed table does not provide a readable, gene-specific phenotype, interaction, or mechanism (publication: November 2009; DOI: https://doi.org/10.1534/genetics.109.107748) (cruz2009againoffunctionscreen pages 8-9).
A 2012 follow-up study again includes CG42404 in a table used to genetically annotate wing-screen candidates, but supplies no gene-specific mechanistic narrative (publication: October 2012; DOI: https://doi.org/10.1534/genetics.112.143537) (molnar2012geneticannotationof pages 4-5).
Therefore, these studies establish only that CG42404 was considered as a candidate near or associated with screen insertions; they do not establish that it controls wing development.
Cellular localization is unknown. No retrieved study reports immunolocalization, fluorescent tagging, biochemical fractionation, secretion assays, or extracellular-matrix incorporation for Q9VFA8.
A VWFC-domain prediction makes an extracellular role biologically conceivable, but it is insufficient to distinguish among extracellular, luminal, membrane-associated, or intracellular localization. Consequently, “secreted protein” and “extracellular-matrix protein” should remain hypotheses rather than annotations.
The evidence is limited to high-throughput genetic-screen tables:
Cruz et al., 2009. CG42404 occurs in the wing gain-of-function screen dataset, but the available table formatting does not permit a reliable gene-specific phenotype or numerical effect to be assigned. The historical identifier CG4285 occurs in another visible table row with assay codes, but those codes are not sufficient to establish a molecular function or even confirm the alias relationship independently (cruz2009againoffunctionscreen pages 13-14, cruz2009againoffunctionscreen pages 8-9).
Molnar et al., 2012. In the visible CG42404 table column, the entries include numeric codes 0 and 2, nE in the in-situ-expression row, and wt in the RNAi-result row. The paper excerpt does not provide a gene-specific sample size, effect estimate, confidence interval, or statistical test. wt indicates no detectable departure from wild type under that particular RNAi assay condition; it is not proof that the gene is dispensable. nE should not be expanded beyond the paper’s table definition without further record-level confirmation (molnar2012geneticannotationof pages 4-5).
These are candidate-level observations rather than precise functional experiments. Negative or wild-type RNAi results can also reflect incomplete knockdown, tissue restriction, developmental timing, redundancy, or assay insensitivity.
No 2023–2024 paper dedicated to Q9VFA8, CG42404, or lincRNA.S6902 was retrieved. No recent structural study, single-cell functional validation, interaction map, mutant characterization, or biochemical assay was found for the exact target. This negative search result does not prove that no record exists, but it indicates that the gene did not acquire a well-supported mechanistic annotation in the literature examined here.
The principal current development is therefore not a new functional discovery but an annotation problem: protein-coding/domain annotations and the lincRNA-like symbol are incongruent and should be reconciled against the latest FlyBase transcript model and UniProt sequence evidence before experimental interpretation.
No clinical, diagnostic, agricultural, or biotechnological application specific to CG42404/Q9VFA8 has been demonstrated. It is not a validated therapeutic or pest-control target. Its present utility is primarily as an uncharacterized candidate for basic functional genomics and as an example where historical gene-model changes complicate annotation.
The evidence supports the following confidence-ranked conclusions:
The most informative next experiments would be: (1) validate whether the locus produces a stable coding transcript and protein; (2) reconcile CG42404 with the historical aliases at exon and genomic-coordinate level; (3) test signal-peptide-dependent secretion and localization using an endogenous tag; (4) create a clean CRISPR null allele rather than relying only on RNAi; (5) perform tissue- and stage-resolved expression analysis; and (6) use affinity purification or extracellular-ligand assays to identify interaction partners. These steps would distinguish a genuine secreted VWFC-domain protein from an obsolete or incorrectly translated gene model.
Q9VFA8/CG42404 (lincRNA.S6902) is an ambiguity-prone, poorly characterized Drosophila melanogaster locus whose supplied sequence predicts IDD and VWFC-related domains. Its primary molecular function, substrate or ligand specificity, biological pathway, and cellular localization remain unknown. Existing wing-screen evidence is insufficient to assign a developmental or biochemical role.
References
(cruz2009againoffunctionscreen pages 13-14): Cristina Cruz, Alvaro Glavic, Mar Casado, and Jose F de Celis. A gain-of-function screen identifying genes required for growth and pattern formation of the drosophila melanogaster wing. Genetics, 183:1005-1026, Nov 2009. URL: https://doi.org/10.1534/genetics.109.107748, doi:10.1534/genetics.109.107748. This article has 73 citations and is from a domain leading peer-reviewed journal.
(cruz2009againoffunctionscreen pages 8-9): Cristina Cruz, Alvaro Glavic, Mar Casado, and Jose F de Celis. A gain-of-function screen identifying genes required for growth and pattern formation of the drosophila melanogaster wing. Genetics, 183:1005-1026, Nov 2009. URL: https://doi.org/10.1534/genetics.109.107748, doi:10.1534/genetics.109.107748. This article has 73 citations and is from a domain leading peer-reviewed journal.
(molnar2012geneticannotationof pages 4-5): Cristina Molnar, Mar Casado, Ana López-Varea, Cristina Cruz, and Jose F de Celis. Genetic annotation of gain-of-function screens using rna interference and in situ hybridization of candidate genes in the drosophila wing. Genetics, 192:741-752, Oct 2012. URL: https://doi.org/10.1534/genetics.112.143537, doi:10.1534/genetics.112.143537. This article has 8 citations and is from a domain leading peer-reviewed journal.